Stock listing

NASDAQ:CVRX CVRx, Inc. Stock

Home listing (NASDAQ) of CVRx, Inc.

Follow CVRx, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CVRX

$0.501 USD -0.103 (-17.1%)

Close on Nov 20, 2026

Past year -94.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.497 – $0.569 USDNov 20, 2026
Volume
519,859 sharesNov 20, 2026
Market cap
$14.27M USDAt the close on Nov 20, 2026 · price × 28.49M shares outstanding
52-week range
$0.497 – $10.280 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.39M USDMedian day 519,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
CVRx, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CVRX · Home$0.501 USD-0.103 (-17.1%)519,859$0.529$0.569$0.497$0.604Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CVRX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.501-0.103-17.1%$0.529$0.569$0.497519,859
$0.604-0.007-1.1%$0.611$0.672$0.604198,157
$0.611-0.002-0.3%$0.640$0.675$0.571637,315
$0.613+0.006+0.9%$0.620$0.620$0.566513,863
$0.607-0.023-3.6%$0.630$0.662$0.604715,780
$0.630-0.070-10.0%$0.698$0.701$0.630591,282
$0.700+0.005+0.7%$0.723$0.740$0.700369,289
$0.695-0.085-10.9%$0.800$0.822$0.6741,109,074
$0.781-0.088-10.2%$0.949$0.966$0.7203,447,204
$0.869-0.601-40.9%$1.250$1.250$0.7745,392,300
$1.470-0.110-7.0%$1.540$1.555$1.405299,300
$1.580+0.200+14.5%$1.400$1.600$1.400368,200
$1.380+0.010+0.7%$1.380$1.450$1.335305,300
$1.370-0.040-2.8%$1.410$1.450$1.340294,100
$1.410-0.015-1.1%$1.410$1.460$1.380272,700
$1.425+0.025+1.8%$1.420$1.455$1.360256,100
$1.400-0.015-1.1%$1.430$1.451$1.280822,300
$1.415-0.035-2.4%$1.440$1.490$1.350447,300
$1.450+0.030+2.1%$1.410$1.470$1.350224,000
$1.420+0.050+3.6%$1.370$1.470$1.300199,900
$1.3700.0000.0%$1.370$1.420$1.360247,500
$1.370-0.020-1.4%$1.380$1.380$1.300282,000
$1.390+0.040+3.0%$1.360$1.435$1.360295,900
$1.350+0.050+3.8%$1.300$1.360$1.275358,000
$1.300-0.090-6.5%$1.390$1.390$1.255382,700
$1.390+0.050+3.7%$1.360$1.440$1.332360,700
$1.340-0.020-1.5%$1.330$1.400$1.280893,200
$1.360-0.120-8.1%$1.490$1.490$1.350489,800
$1.480-0.100-6.3%$1.580$1.665$1.465470,100
$1.580-0.100-6.0%$1.660$1.680$1.560398,700
$1.680+0.010+0.6%$1.640$1.680$1.550519,200
$1.670+0.050+3.1%$1.620$1.760$1.620896,600
$1.620+0.060+3.8%$1.540$1.690$1.540537,100
$1.560+0.010+0.6%$1.570$1.620$1.505576,600
$1.550+0.020+1.3%$1.580$1.665$1.5101,059,600
$1.530-0.220-12.6%$1.745$1.790$1.5001,463,800
$1.750-0.880-33.5%$2.630$2.650$1.6504,274,900
$2.630+0.040+1.5%$2.600$2.755$2.530373,400
$2.590-0.110-4.1%$2.690$2.790$2.530382,000
$2.700+0.170+6.7%$2.560$2.700$2.510461,600
$2.530-0.190-7.0%$2.730$2.730$2.510693,700
$2.720-0.170-5.9%$2.890$2.890$2.700481,700
$2.890-0.080-2.7%$2.950$3.070$2.860666,200
$2.970-0.070-2.3%$3.030$3.060$2.910289,100
$3.040+0.040+1.3%$2.990$3.065$2.920810,500
$3.000-0.020-0.7%$3.040$3.100$2.975301,200
$3.020+0.020+0.7%$2.990$3.130$2.920415,900
$3.0000.0000.0%$2.990$3.080$2.850494,900
$3.000+0.120+4.2%$2.860$3.000$2.790548,400
$2.880+0.020+0.7%$2.860$2.901$2.7501,001,400
$2.860+0.030+1.1%$2.830$2.860$2.700372,900
$2.830-0.100-3.4%$2.900$2.950$2.760555,200
$2.930-0.120-3.9%$3.030$3.050$2.810619,600
$3.050+0.040+1.3%$2.990$3.110$2.960856,000
$3.010-0.060-2.0%$3.110$3.175$2.980613,900
$3.070+0.030+1.0%$3.060$3.160$2.962530,000
$3.040+0.080+2.7%$2.930$3.060$2.895780,700
$2.960+0.010+0.3%$2.970$2.990$2.810737,800
$2.950-0.090-3.0%$3.030$3.150$2.940496,700
$3.040-0.230-7.0%$3.250$3.290$3.020447,500
$3.270-0.100-3.0%$3.310$3.400$3.150884,400
$3.370+0.220+7.0%$3.170$3.420$3.1301,123,956
$3.150+0.310+10.9%$2.990$3.290$2.8601,620,454
$2.8400.0000.0%$2.860$2.960$2.820742,100
$2.840+0.020+0.7%$2.810$2.951$2.770746,500
Ticker
NASDAQ:CVRX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All CVRx, Inc. news

CVRx, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
30 in the last 12 months · 115 in all · newest Nov 17, 2026 · oldest 2021
Calls
22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
Decks
16 decks · latest Jun 8, 2023

Where CVRx, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CVRX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:CVRXBOATSUnited StatesUSD

Valuation

EV/sales 0.2× against a median of 0.8×: 2nd lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$14.18M USD
P/E
Loss
EV/sales
0.2×
EV/EBITDA
Negative EBITDA
Price/book
1.0×
Gross margin
86.9%
Operating margin
−81.9%
Net margin
−88.3%
Debt to equity
4.2×
Beta vs S&P 500
1.28

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
CVRx, Inc. · NASDAQ:CVRXUS$14.27MUS$14.18Mn/a0.2×n/a1.0×−88.3%4.2×1.28
SG Healthcare Co., Ltd. · KRX:398120US$15.78MUS$11.93M19.3×0.6×n/a0.9×4.2%0.0×n/a
Careplus Group Bhd. · MYX:CAREPLSUS$15.50MUS$20.64Mn/a0.8×n/a0.3×−11.1%0.1×n/a
HeartBeam, Inc. · NASDAQ:BEATUS$15.50MUS$9.44Mn/an/an/a2.4×n/a0.0×1.93
Lifecare ASA · OSL:LIFEUS$15.21MUS$11.43Mn/a175×n/a2.7×n/a0.0×n/a
Control Bionics Ltd. · ASX:CBLUS$15.13MUS$14.16Mn/a4.5×n/a3.6×−152.4%0.1×n/a
Micro-X Ltd. · ASX:MX1US$14.45MUS$16.66Mn/a1.7×n/a4.5×−65.5%1.3×n/a
Perimeter Medical Imaging AI Inc · TSXV:PINKUS$14.45MUS$8.00Mn/a3.8×n/a3.5×−478.7%0.0×1.55
Suzhou Basecare Medical Corp. Ltd. Class H · HKEX:2170US$13.52MUS$8.12Mn/a0.2×n/a0.1×−66.8%0.4×n/a
CytoSorbents Corporation · NASDAQ:CTSOUS$13.12MUS$26.43Mn/a0.7×n/an/a−46.7%n/a1.42
SANUWAVE Health, Inc. · NASDAQ:SNWVUS$12.90MUS$24.87M3.1×0.6×34.8×4.5×10.1%6.5×0.88
Median of the othersUS$14.79MUS$13.05M11.2×0.8×34.8×2.7×−56.1%0.1×1.49

Forecasts

1 strong buy · 5 hold · 1 sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
1.65 USD · Analysts' mean
EPS, year to Dec 2026
-2.07 · 7 analysts
Revenue, year to Dec 2026
56.4M · 7 analysts

Team and board

Officers

OfficerRole
Kevin HykesPresident and CEO
Martha ShadanPresident and Chief Executive Officer
Michael DaleChief Executive Officer and President
John LandryChief Financial Officer
Joseph SlatteryExecutive Vice President and Chief Financial Officer
Brent BinkowskiChief Operating Officer
Greg MorrisonChief Human Resources Officer
Philip B. AdamsonChief Medical Officer

Board

DirectorRole
Kirk NielsenDirector
Mitch HillDirector
Mudit K. JainDirector

Events

Calls

CallWhenStatus
CVRx (NASDAQ:CVRX) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q2 2026 Earnings CallThu, Aug 06, 2026 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q1 2026 Earnings CallMon, May 11, 2026 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q4 2025 Earnings CallThu, Feb 12, 2026 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q3 2025 Earnings CallWed, Nov 05, 2025 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q2 2025 Earnings CallMon, Aug 04, 2025 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q1 2025 Earnings CallThu, May 08, 2025 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q4 2024 Earnings CallTue, Feb 04, 2025 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q3 2024 Earnings CallTue, Oct 29, 2024 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q2 2024 Earnings CallMon, Jul 29, 2024 · 4:30 PM ETReplay
All 22 calls
CallWhenStatus
CVRx (NASDAQ:CVRX) Q1 2024 Earnings CallTue, Apr 30, 2024 · 5:00 PM ETReplay
CVRx (NASDAQ:CVRX) Q4 2023 Earnings CallThu, Jan 25, 2024 · 8:00 AM ETReplay
CVRx (NASDAQ:CVRX) Q3 2023 Earnings CallThu, Oct 26, 2023 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q2 2023 Earnings CallTue, Jul 25, 2023 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q1 2023 Earnings CallThu, Apr 27, 2023 · 5:00 PM ETReplay
CVRx (NASDAQ:CVRX) Q4 2022 Earnings CallThu, Jan 26, 2023 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q3 2022 Earnings CallTue, Nov 01, 2022 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q2 2022 Earnings CallThu, Jul 28, 2022 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q1 2022 Earnings CallMon, Apr 25, 2022 · 4:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q4 2021 Earnings CallTue, Feb 15, 2022 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q3 2021 Earnings CallThu, Nov 04, 2021 · 5:30 PM ETReplay
CVRx (NASDAQ:CVRX) Q2 2021 Earnings CallWed, Aug 04, 2021 · 5:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close−40.9%
Q2 2026Aug 6, 2026 · After close−59.8%
Q1 2026May 11, 2026 · After close−23.8%
Q4 2025Feb 12, 2026 · After close−13.0%
Q3 2025Nov 5, 2025 · After close+2.7%
Q2 2025Aug 4, 2025 · After close−9.9%
Q1 2025May 8, 2025 · After close−38.7%
Q4 2024Feb 4, 2025 · After close−7.2%
Q3 2024Oct 29, 2024 · After close+31.0%
Q2 2024Jul 29, 2024 · After close−14.5%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 30, 2024 · After close−34.8%
Q4 2023Jan 25, 2024 · After close−6.8%
Q3 2023Oct 26, 2023 · After close+2.4%
Q2 2023Jul 25, 2023 · After close+5.4%
Q1 2023Apr 27, 2023 · After close+22.8%
Q4 2022Jan 26, 2023 · After close+2.9%
Q3 2022Nov 1, 2022 · After close+1.1%
Q2 2022Jul 28, 2022 · After close+16.9%
Q1 2022Apr 25, 2022 · After close+11.4%
Q4 2021Feb 15, 2022 · After close−6.3%

Open Events

Decks

DeckKindSlidesDate
43rd Annual William Blair Growth Stock Conference, June 2023Conference22 slidesJun 8, 2023
Technical Presentation (March 2023)Technical36 slidesMar 21, 2023
Technical Presentation (February 2022)Technical8 slidesFebruary 2022
Technical Presentation (May 2013)Technical16 slidesMay 2013
Technical Presentation (May 2013)Technical24 slidesMay 2013
Technical Presentation (May 2013)Technical19 slidesMay 2013
Technical Presentation (May 2013)Technical11 slidesMay 2013
Technical Presentation (May 2013)Technical9 slidesMay 2013
Technical Presentation (August 2012)Technical19 slidesAug 30, 2012
American College of Cardiology, 61st Annual Scientific Sessions (March 2012)Conference16 slidesMar 25, 2012
All 16 decks
DeckKindSlidesDate
Technical Presentation (2011)Technical19 slidesOct 5, 2011
Technical Presentation (2011)Technical21 slidesOct 5, 2011
Technical Presentation (October 2011)Technical23 slidesOctober 2011
Technical Presentation (August 2011)Technical11 slidesAug 30, 2011
Technical Presentation (October 2009)Technical13 slidesOct 3, 2009
Technical Presentation (April 2009)Technical15 slidesApr 8, 2009

Open Decks

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$9.5M in the latest tranche
Apr 7, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$18.00 a share on Jun 29, 2021.

Price
US$18.00 a share
Shares offered
7,000,000 shares of common stock
Offering size
US$126 million
Underwriters' option
Up to 1,050,000 more shares
Listing
CVRX on the Nasdaq Global Select Market
Underwriters
J.P. Morgan, Piper Sandler, William Blair, Canaccord Genuity · In the order on the cover
Shares delivered
On or about Jul 2, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceApr 9, 2021
Filed publiclyJun 4, 2021
Amended onceJun 23, 2021
Shares registered with an exchangeJun 25, 2021
Declared effective by the SECJun 29, 2021
Final prospectus, with the priceJul 1, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jul 1, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue56.7M51.3M39.3M22.5M13.0M6.05M6.26M
Cost of revenue8.31M8.33M6.26M5.00M3.64M1.44M1.68M
Gross profit48.3M43.0M33.0M17.5M9.40M4.61M4.57M
Research and development11.1M11.1M11.6M9.95M7.50M6.41M8.66M
Selling, general and administrative88.5M91.3M64.5M50.0M27.9M9.72M6.11M
Operating income-51.3M-59.5M-43.1M-42.5M-26.0M-11.5M-10.2M
Depreciation and amortization756.0K619.0K522.0K412.0K168.0K75.0K56.0K
EBITDA-50.5M-58.9M-42.6M-42.1M-25.8M-11.4M-10.1M
Interest expense5.83M4.40M1.80M165.0K2.22M2.47M1.72M
Income before tax-53.3M-59.9M-41.1M-41.3M-43.0M-14.0M-14.6M
Income tax-18.0K55.0K147.0K109.0K91.0K85.0K73.0K
Net income-53.3M-60.0M-41.2M-41.4M-43.1M-14.1M-14.6M
Earnings per share, basic-2.04-2.65-1.99-2.02-4.16-37.01-30.32
Earnings per share, diluted-2.04-2.65-1.99-2.02-4.16-37.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents75.7M105.9M90.6M106.2M142.1M59.1M25.7M
Receivables10.7M9.27M7.60M5.50M2.56M1.28M719.0K
Inventory12.2M12.1M11.0M6.96M3.88M3.34M2.07M
Current assets101.6M129.8M112.1M122.9M151.1M64.3M28.9M
Property, plant and equipment2.24M2.50M1.76M1.70M1.43M410.0K174.0K
Total assets104.8M133.4M115.2M124.9M152.5M64.8M29.1M
Accounts payable3.83M2.58M1.88M1.72M510.0K483.0K437.0K
Current liabilities13.3M10.8M7.86M8.09M5.91M7.98M8.61M
Long-term debt49.5M49.3M29.2M6.75M019.3M19.0M
Total debt49.5M49.3M29.2M6.75M019.3M19.0M
Total liabilities65.5M62.4M39.3M15.8M6.59M28.0M308.1M
Shareholders' equity39.3M71.1M75.9M109.2M146.0M-293.2M-279.0M
Shares outstanding26.3M25.3M20.9M20.7M20.4M360.4K482.6K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-40.2M-39.1M-39.0M-42.7M-27.7M-16.1M-12.8M
Capital spending-580.0K-1.36M-591.0K-685.0K-1.18M-311.0K-106.0K
Free cash flow-40.8M-40.5M-39.6M-43.4M-28.9M-16.4M-12.9M
Cash from investing-580.0K-1.36M-591.0K-685.0K-1.18M-311.0K-106.0K
Cash from financing10.5M55.9M24.0M7.49M111.9M49.8M29.5M
Share buybacks771.0K-1.00K0
Change in cash-30.2M15.4M-15.6M-35.9M83.0M33.4M16.7M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 12, 2026Insider tradeSEC
3 · Initial statement of ownershipNov 12, 2026Insider tradeSEC
S-8 · Registration statement for employee plansNov 5, 2026Offer documentSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 2, 2026Big-stake noticeSEC
8-K · Current reportSep 21, 2026Management or board changeSEC
SCHEDULE 13D · Big-stake noticeAug 24, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipAug 13, 2026Insider tradeSEC
8-K · Current reportAug 11, 2026Management or board changeSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
8-K · Current reportJun 9, 2026Management or board changeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 3, 2026Insider tradeSEC
8-K · Current reportJun 3, 2026Meeting outcomeSEC
SD · Specialized disclosureMay 28, 2026ESG reportSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
8-K · Current reportMay 11, 2026ResultsSEC
DEFA14A · Additional proxy materialApr 20, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 20, 2026Meeting noticeSEC
8-K · Current reportApr 13, 2026ResultsSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
8-K · Current reportMar 3, 2026Management or board changeSEC
4 · Change in ownershipFeb 23, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
S-8 · Registration statement for employee plansFeb 13, 2026Offer documentSEC
10-K · Annual reportFeb 13, 2026Annual reportSEC
8-K · Current reportFeb 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 12, 2026Big-stake noticeSEC
8-K · Current reportJan 12, 2026Material contractSEC
424B5 · ProspectusJan 12, 2026Offer documentSEC
8-K · Current reportJan 12, 2026ResultsSEC
4/A · Change in ownership, amendedJan 8, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveDec 16, 2025Other filingsSEC
CORRESP · Letter to the SECDec 11, 2025Other filingsSEC
4 · Change in ownershipDec 1, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
DEL AMNov 17, 2025Other filingsSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
S-3 · Registration statementNov 6, 2025Offer documentSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
3 · Initial statement of ownershipAug 13, 2025Insider tradeSEC
10-Q · Quarterly reportAug 5, 2025Quarterly reportSEC
8-K · Current reportAug 4, 2025ResultsSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
4 · Change in ownershipJun 5, 2025Insider tradeSEC
8-K · Current reportJun 5, 2025Meeting outcomeSEC
SD · Specialized disclosureMay 23, 2025ESG reportSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
DEFA14A · Additional proxy materialApr 23, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 23, 2025Meeting noticeSEC
8-K · Current reportApr 7, 2025ResultsSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 20, 2025Big-stake noticeSEC
S-8 · Registration statement for employee plansFeb 18, 2025Offer documentSEC
10-K · Annual reportFeb 18, 2025Annual reportSEC
3 · Initial statement of ownershipFeb 14, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 6, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2025Big-stake noticeSEC
8-K · Current reportFeb 4, 2025ResultsSEC
8-K · Current reportJan 13, 2025ResultsSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
4 · Change in ownershipNov 21, 2024Insider tradeSEC
144 · Notice of proposed saleNov 19, 2024Other filingsSEC
144 · Notice of proposed saleNov 18, 2024Other filingsSEC
SC 13D/A · Big-stake notice, amendedNov 7, 2024Big-stake noticeSEC
144 · Notice of proposed saleNov 5, 2024Other filingsSEC
144 · Notice of proposed saleNov 5, 2024Other filingsSEC
8-K · Current reportNov 4, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 1, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 1, 2024Quarterly reportSEC
8-K · Current reportOct 29, 2024ResultsSEC
8-K · Current reportOct 1, 2024FinancingSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 5, 2024Insider tradeSEC
3 · Initial statement of ownershipSep 5, 2024Insider tradeSEC
8-K · Current reportSep 3, 2024Management or board changeSEC
4 · Change in ownershipAug 15, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 6, 2024Insider tradeSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
10-Q · Quarterly reportAug 2, 2024Quarterly reportSEC
8-K · Current reportJul 29, 2024ResultsSEC
144 · Notice of proposed saleJul 26, 2024Other filingsSEC
144 · Notice of proposed saleJul 25, 2024Other filingsSEC
144 · Notice of proposed saleJul 24, 2024Other filingsSEC
144 · Notice of proposed saleJul 23, 2024Other filingsSEC
144 · Notice of proposed saleJul 22, 2024Other filingsSEC
144 · Notice of proposed saleJul 16, 2024Other filingsSEC
4 · Change in ownershipJul 1, 2024Insider tradeSEC
3 · Initial statement of ownershipJul 1, 2024Insider tradeSEC
4/A · Change in ownership, amendedJun 7, 2024Insider tradeSEC
4/A · Change in ownership, amendedJun 7, 2024Insider tradeSEC
4/A · Change in ownership, amendedJun 7, 2024Insider tradeSEC
4/A · Change in ownership, amendedJun 7, 2024Insider tradeSEC
4/A · Change in ownership, amendedJun 7, 2024Insider tradeSEC
8-K · Current reportJun 7, 2024Meeting outcomeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
8-K · Current reportJun 5, 2024Current reportSEC
SD · Specialized disclosureMay 16, 2024ESG reportSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportApr 30, 2024ResultsSEC
DEFA14A · Additional proxy materialApr 23, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 23, 2024Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 11, 2024Meeting noticeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipFeb 27, 2024Insider tradeSEC
4 · Change in ownershipFeb 22, 2024Insider tradeSEC
144 · Notice of proposed saleFeb 20, 2024Other filingsSEC
4 · Change in ownershipFeb 14, 2024Insider tradeSEC
S-8 · Registration statement for employee plansFeb 9, 2024Offer documentSEC
S-8 · Registration statement for employee plansFeb 9, 2024Offer documentSEC
10-K · Annual reportFeb 9, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 6, 2024Big-stake noticeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
4 · Change in ownershipFeb 6, 2024Insider tradeSEC
4/A · Change in ownership, amendedFeb 2, 2024Insider tradeSEC
3/A · Initial statement of ownership, amendedFeb 2, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 2, 2024Big-stake noticeSEC
4 · Change in ownershipJan 31, 2024Insider tradeSEC
8-K · Current reportJan 31, 2024Management or board changeSEC
8-K · Current reportJan 25, 2024ResultsSEC
SC 13D/A · Big-stake notice, amendedJan 19, 2024Big-stake noticeSEC
8-K · Current reportJan 8, 2024ResultsSEC
4 · Change in ownershipJan 2, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 29, 2023Big-stake noticeSEC
8-K · Current reportDec 26, 2023Current reportSEC
4 · Change in ownershipDec 18, 2023Insider tradeSEC
8-K · Current reportDec 15, 2023FinancingSEC
10-Q · Quarterly reportOct 31, 2023Quarterly reportSEC
8-K · Current reportOct 26, 2023ResultsSEC
4 · Change in ownershipOct 18, 2023Insider tradeSEC
4 · Change in ownershipSep 20, 2023Insider tradeSEC
3 · Initial statement of ownershipSep 18, 2023Insider tradeSEC
4 · Change in ownershipSep 18, 2023Insider tradeSEC
144 · Notice of proposed saleAug 10, 2023Other filingsSEC
4 · Change in ownershipAug 7, 2023Insider tradeSEC
10-Q · Quarterly reportAug 3, 2023Quarterly reportSEC
4 · Change in ownershipAug 2, 2023Insider tradeSEC
8-K · Current reportJul 25, 2023ResultsSEC
8-K · Current reportJun 8, 2023Meeting outcomeSEC
4 · Change in ownershipJun 7, 2023Insider tradeSEC
4 · Change in ownershipJun 7, 2023Insider tradeSEC
4 · Change in ownershipJun 7, 2023Insider tradeSEC
4 · Change in ownershipJun 7, 2023Insider tradeSEC
4 · Change in ownershipJun 7, 2023Insider tradeSEC
4 · Change in ownershipJun 7, 2023Insider tradeSEC
SD · Specialized disclosureMay 26, 2023ESG reportSEC
4 · Change in ownershipMay 18, 2023Insider tradeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportApr 27, 2023ResultsSEC
DEFA14A · Additional proxy materialApr 21, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 21, 2023Meeting noticeSEC
8-K · Current reportMar 21, 2023Current reportSEC
8-K · Current reportMar 15, 2023FinancingSEC
8-K · Current reportFeb 21, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
S-8 · Registration statement for employee plansFeb 10, 2023Offer documentSEC
10-K · Annual reportFeb 10, 2023Annual reportSEC

This page holds 200 of 350 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from CVRx, Inc.’s releases · as of Oct 29, 2026

Common shares
28,485,019
Fully diluted
28,485,019

Fully diluted

LineSharesAs of
Common shares28,485,019Oct 29, 2026

Share count over time

CountShares
Oct 29, 202628,485,019

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Johnson & Johnson4.02M14.1%US$7.04MSep 30, 2026
NEA Management Company, LLC1.95M6.9%US$3.42MSep 30, 2026
BlackRock1.29M4.5%US$2.25MSep 30, 2026
Vanguard1.14M4.0%US$2MSep 30, 2026
GSK plc1.01M3.5%US$1.76MSep 30, 2026
Citadel652K2.3%US$1.14MSep 30, 2026
RBC517K1.8%US$905KSep 30, 2026
Renaissance Technologies435K1.5%US$762KSep 30, 2026
Geode Capital423K1.5%US$741KSep 30, 2026
Goldman Sachs372K1.3%US$651KSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
State Street347K1.2%US$606KSep 30, 2026
Morgan Stanley274K0.96%US$479KSep 30, 2026
First Eagle Investment Management, LLC221K0.77%US$386KSep 30, 2026
Tudor Investment Corp Et Al208K0.73%US$364KSep 30, 2026
D. E. Shaw & Co., Inc.201K0.70%US$351KSep 30, 2026
Accredited Investors Inc.200K0.70%US$350KSep 30, 2026
UBS190K0.67%US$332KSep 30, 2026
Two Sigma158K0.56%US$277KSep 30, 2026
Jacobs Levy Equity Management, Inc153K0.54%US$267KSep 30, 2026
Northern Trust128K0.45%US$223KSep 30, 2026
AQR Capital Management LLC121K0.42%US$211KSep 30, 2026
Cresset Asset Management, LLC116K0.41%US$204KSep 30, 2026
Russell Investments Group, Ltd.101K0.35%US$177KSep 30, 2026
XTX Topco Ltd100K0.35%US$175KSep 30, 2026
Jump Financial, LLC97,6730.34%US$171KSep 30, 2026
Kestra Advisory Services, LLC84,5000.30%US$148KSep 30, 2026
Citigroup Inc77,9910.27%US$136KSep 30, 2026
Centiva Capital, LP77,9310.27%US$136KSep 30, 2026
Arax Advisory Partners71,9170.25%US$126KSep 30, 2026
BNP Paribas56,0730.20%US$98,128Sep 30, 2026
Nuveen52,4140.18%US$91,725Sep 30, 2026
State of Alaska, Department of Revenue50,0000.18%US$87,000Sep 30, 2026
Quadrature Capital Ltd47,3740.17%US$82,905Sep 30, 2026
Gsa Capital Partners LLP45,7840.16%US$80,000Sep 30, 2026
Bridgeway Capital Management, LLC40,2900.14%US$70,508Sep 30, 2026
BNY36,9060.13%US$64,587Sep 30, 2026
Jain Global LLC36,4400.13%US$63,770Sep 30, 2026
Empowered Funds, LLC35,8900.13%US$62,808Sep 30, 2026
Schwab35,4230.12%US$61,990Sep 30, 2026
Dimensional30,6230.11%US$55,894Sep 30, 2026
Graham Capital Management, L.P.29,2980.10%US$51,272Sep 30, 2026
Bank of America26,3130.09%US$46,048Sep 30, 2026
AllianceBernstein23,3600.08%US$40,880Sep 30, 2026
JPMorgan20,0340.07%US$52,690Sep 30, 2026
RBF Capital, LLC20,0000.07%US$35,000Sep 30, 2026
MUFG18,8810.07%US$33,042Sep 30, 2026
Rhumbline Advisers18,2250.06%US$31,888Sep 30, 2026
Philadelphia Trust Co15,0000.05%US$26,000Sep 30, 2026
R Squared Ltd13,4930.05%US$23,613Sep 30, 2026
Fidelity13,1010.05%US$22,927Sep 30, 2026

This page holds 50 of 83 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund684K2.4%US$3.52MJun 30, 2026
iShares Russell 2000 ETF372K1.3%US$1.91MJun 30, 2026
Vanguard Extended Market Index Fund205K0.72%US$1.05MJun 30, 2026
Fidelity Small Cap Index Fund166K0.58%US$859KJul 31, 2026
iShares Russell 2000 Growth ETF156K0.55%US$802KJun 30, 2026
Fidelity Extended Market Index Fund96,3270.34%US$538KMay 31, 2026
Vanguard Russell 2000 Index Fund81,9340.29%US$457KMay 31, 2026
iShares Micro-Cap ETF51,5970.18%US$265KJun 30, 2026
Ultra-Small Company Market Fund36,5000.13%US$188KJun 30, 2026
Schwab Small-Cap Index Fund35,3980.12%US$183KJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Fidelity Total Market Index Fund34,3300.12%US$192KMay 31, 2026
U.S. Small Cap Equity Fund32,9260.12%US$170KJul 31, 2026
Dimensional U.S. Small Cap ETF28,3630.10%US$147KJul 31, 2026
Fidelity Series Total Market Index Fund27,8370.10%US$155KMay 31, 2026
Goldman Sachs Small Cap Equity Insights Fund27,8220.10%US$144KJul 31, 2026
Nuveen Equity Index Fund27,2160.10%US$141KJul 31, 2026
Master Small Cap Index Series23,0440.08%US$118KJun 30, 2026
Nuveen Small Cap Blend Index Fund22,1200.08%US$114KJul 31, 2026
Goldman Sachs Small Cap Growth Insights Fund17,9970.06%US$93,134Jul 31, 2026
EQ/2000 Managed Volatility Portfolio16,0210.06%US$82,348Jun 30, 2026
Fidelity Nasdaq Composite Index Fund15,9820.06%US$89,180May 31, 2026
U.S. Small Cap Portfolio15,8650.06%US$82,101Jul 31, 2026
Goldman Sachs Absolute Return Tracker Fund15,0590.05%US$77,403Jun 30, 2026
Vanguard Russell 2000 Growth Index Fund14,6950.05%US$81,998May 31, 2026
Fidelity Small Cap Growth Index Fund14,5680.05%US$74,880Jun 30, 2026
EQ/AB Small Cap Growth Portfolio14,3800.05%US$73,913Jun 30, 2026
Vanguard Balanced Index Fund13,7720.05%US$70,788Jun 30, 2026
LVIP State Street Small-Cap Index Fund11,4000.04%US$58,596Jun 30, 2026
Goldman Sachs Variable Insurance Trust Small Cap Equity Insights Fund10,9700.04%US$56,386Jun 30, 2026
NVIT GS Small Cap Equity Insights Fund9,2580.03%US$47,586Jun 30, 2026
EQ/Small Company Index Portfolio8,9800.03%US$46,157Jun 30, 2026
Fidelity ZERO Total Market Index Fund8,2430.03%US$42,658Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund8,1500.03%US$41,891Jun 30, 2026
Global X Russell 2000 ETF7,3520.03%US$38,047Jul 31, 2026
U.S. Micro Cap Portfolio6,5080.02%US$33,679Jul 31, 2026
GuideMark Small/Mid Cap Core Fund6,2210.02%US$31,976Jun 30, 2026
Fidelity ZERO Extended Market Index Fund6,0640.02%US$31,381Jul 31, 2026
Small Cap Index Fund5,8310.02%US$32,537May 31, 2026
Small Cap Index Fund5,6480.02%US$29,031Jun 30, 2026
Dimensional U.S. Core Equity 2 ETF5,3670.02%US$27,774Jul 31, 2026
iShares Russell 3000 ETF5,1670.02%US$26,558Jun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio5,0000.02%US$25,700Jun 30, 2026
JNL/DFA U.S. Small Cap Fund4,2400.01%US$21,794Jun 30, 2026
NVIT Small Cap Index Fund3,6500.01%US$18,761Jun 30, 2026
1290 VT Micro Cap Portfolio3,5020.01%US$18,000Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio3,4320.01%US$17,640Jun 30, 2026
Fidelity Flex Small Cap Index Fund3,1580.01%US$16,343Jul 31, 2026
Bridge Builder Small/Mid Cap Growth Fund2,9910.01%US$15,374Jun 30, 2026
Siit Extended Market Index Fund2,9000.01%US$16,182May 31, 2026
Small-Cap Index Portfolio2,625<0.01%US$13,493Jun 30, 2026

This page holds 50 of 93 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Binkowski Brent
Officer: CHIEF OPERATING OFFICER
Buy26,223USD 2.91US$76,309Aug 13, 2026
Binkowski Brent
Officer: CHIEF OPERATING OFFICER
Sale1,309USD 2.55US$3,338Aug 12, 2026

Big stakes

StakeStakeSharesDateFiling
Johnson & Johnson15.40%4.02MDec 31, 2025Schedule 13G
New Enterprise Associates 10, Limited Partnership7.80%2.03MFeb 18, 2025Schedule 13D
Kirk Nielsen7.20%1.76MDec 31, 2024Schedule 13G
Cooperatieve Gilde Healthcare IV U.A.4.90%1.23MFeb 4, 2025Schedule 13D
Chernett Jorey0.62%165KSep 30, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ali Behbahani
Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); NeueHealth Inc (Director · Since at least Oct 2, 2025); Korro Bio, Inc. (Director · Since at least Nov 3, 2023); Arcellx Inc (Director · Since at least Feb 3, 2022); Monte Rosa Therapeutics, Inc. (Director · Since at least Jun 23, 2021); Nkarta, Inc. (Director · Since at least Jul 9, 2020); Black Diamond Therapeutics, Inc. (Director · Since at least Jan 29, 2020); Adaptimmune Therapeutics PLC (Director · Since at least Jul 2, 2019); CRISPR Therapeutics AG (Director · Since at least Jun 11, 2019); Minerva Surgical, Inc. (Director · Oct 21, 2021 – Jun 10, 2022 · Past); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 3, 2023 · Past)
Director · Jun 29, 2021 – Jun 4, 2024 · Past
Joseph Slattery
Other companies: ImageneBio, Inc. (Director · Since at least Nov 1, 2025); Replimune Group, Inc. (Director · Since at least Jul 19, 2018); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Morphic Holding Inc (Director · Jun 26, 2019 – Aug 16, 2024 · Past); Asensus Surgical Inc (EVP and CFO · Oct 2, 2013 – May 13, 2019 · Past); Baxano Surgical Inc (Executive V.P. and CFO · Nov 29, 2007 – May 31, 2013 · Past); Digene Corp (Chief Financial Officer & SVP · Jan 27, 2006 – Nov 20, 2006 · Past)
Executive Vice President and Chief Financial Officer · Since at least Jun 29, 2021
Geoffrey B Pardo
Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Shoulder Innovations, Inc. (Director · Since at least Jul 30, 2025); Inari Medical Inc (Director · May 21, 2020 – May 27, 2020 · Past); Vapotherm Inc (Director · Nov 13, 2018 – Jul 24, 2019 · Past)
Director · Jun 29, 2021 – Jul 2, 2021 · Past
Kevin J Ballinger
Other companies: Shockwave Medical Inc (Director · May 16, 2023 – May 31, 2024 · Past); Silk Road Medical Inc (Director · Dec 3, 2020 – Sep 17, 2024 · Past); Boston Scientific Corporation (EVP & Pres, Interven Cardio · Jan 1, 2013 – Mar 3, 2020 · Past)
Director · Since at least Sep 3, 2024
Mitch C Hill
Other companies: Inari Medical Inc (Chief Financial Officer · May 21, 2020 – Oct 1, 2024 · Past); Ominto Inc (Director · Aug 10, 2015 – Jun 20, 2017 · Past)
Director · Since at least Sep 3, 2024
Gregory Morrison
Other companies: Wright Medical Group N.V (SVP, Human Resources · Jun 2, 2016 – Nov 10, 2017 · Past)
CHIEF HUMAN RESOURCES OFFICER · Since at least Mar 2, 2026
John Landry
Other companies: Vapotherm Inc (SVP & Chief Financial Officer · Nov 13, 2018 – Sep 20, 2024 · Past)
Chief Financial Officer · Since at least Sep 21, 2026
John M Nehra
Other companies: DaVita Inc. (Director · Mar 31, 2013 – May 15, 2024 · Past)
Director · Jun 29, 2021 – Jun 7, 2022 · Past
Kirk Nielsen
Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026)
Director · Since at least May 12, 2025
Martha Shadan
Other companies: LeMaitre Vascular, Inc. (Director · Since at least May 29, 2025)
President and Chief Executive Officer · Since at least Jun 3, 2025
All 25 people
PersonSeat
Michael Dale
Other companies: Axogen, Inc. (President, Chief Executive Officer and Board Director · Since at least Oct 28, 2026)
Chief Executive Officer and President · Since at least Apr 20, 2026
Brent BinkowskiChief Operating Officer · Since at least Aug 4, 2025
Craig E PalmerSVP, U.S. SALES · Aug 2, 2022 – Mar 25, 2024 · Past
Dean Bruhn-DingVP OF REG. AFFAIRS AND QA · Jun 29, 2021 – Aug 2, 2022 · Past
Greg MorrisonChief Human Resources Officer · Since at least Nov 4, 2026
Jared OasheimCHIEF FINANCIAL OFFICER · Since at least Jun 29, 2021
John BrintnallCHIEF STRATEGY OFFICER AND SEC · Jun 29, 2021 – Apr 22, 2022 · Past
Kevin HykesPresident and CEO · Since at least Feb 12, 2024
Liz GalleVP OF GLOBAL CLINICAL RESEARCH · Jun 29, 2021 – Oct 16, 2023 · Past
Mitch HillDirector · Since at least Jun 3, 2026
Mudit K. JainDirector · Since at least Jun 29, 2021
Paul VerrastroCHIEF MKTG & STRAT OFFICER · Since at least Jun 29, 2021
Philip B AdamsonChief Medical Officer · Since at least Feb 4, 2025
Philip B. AdamsonChief Medical Officer · Since at least Jan 22, 2026
Robert Allen JohnChief Revenue Officer · Since at least Jun 27, 2024

Open People

Log in to ask 6ix AI your own questions about CVRx, Inc.